Iain Robert Greig

USPTO Granted Patents = 20 (Patent Applications = 4)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 4.6

ph-index = 10

Forward Citations = 169(Granted Patents)

Location History:

Aberdeenshire, GB (2013 - 2014)
Aberdeen, GB (2009 - 2019)

Company Filing History:

The University Court of the University of Aberdeen

University of Toronto

patents

5. 1 out of 47

Centre for Addiction and Mental Health

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12398139 - Modulators of AMPA receptor signaling (2025-08-26),

2. 12344587 - Synthetic retinoids for use in RAR activation (2025-07-01),

3. 10377711 - Cannabinoid type 1 receptor modulators (2019-08-13),

4. 10233147 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use (2019-03-19),

5. 10029979 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use (2018-07-24),

6. 10005733 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and their therapeutic use (2018-06-26),

7. 9796670 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use (2017-10-24),

8. 9624167 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use (2017-04-18),

9. 9616037 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2017-04-11),

10. 9302984 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2016-04-05),

11. 9050329 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2015-06-09),

12. 8822507 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2014-09-02),

13. 8524778 - Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents (2013-09-03),

14. 8435968 - Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use (2013-05-07),

15. 8207167 - Aryl-phenyl-sulfonamide-phenylene compounds and their use (2012-06-26),

Title: The Innovative Mind of Iain Robert Greig

Introduction

Iain Robert Greig, a prominent inventor based in Aberdeenshire, GB, has made significant contributions to the field of therapeutic compounds, holding an impressive portfolio of 18 patents. His innovative work primarily focuses on advancements in pharmaceuticals, particularly those targeting various diseases through modulation of specific receptors.

Latest Patents

Among his latest patents are formulations related to cannabinoid type 1 receptor modulators. These indole derivatives are impactful for treating diseases where modulation of the receptor is beneficial. Greig's inventions further include N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides, which are therapeutic compounds designed to address a broad spectrum of disorders. These can range from autoimmune diseases such as rheumatoid arthritis to various types of cancers, inflammatory bowel disease, and even rare vasculitides like Behçet's disease. His work not only emphasizes the preparation of these compounds but also their pharmaceutical applications, showcasing his commitment to addressing complex health issues.

Career Highlights

Iain's career is marked by his affiliation with notable organizations, including Pimco 2664 Limited and the University Court of the University of Aberdeen. His work at these institutions has allowed him to focus on research and development, further propelling his innovation in therapeutic compounds.

Collaborations

Throughout his career, Iain Robert Greig has collaborated with skilled professionals, including Rose Mary Sheridan and Raymond Fisher, to enhance his inventions and broaden the impact of his work in the pharmaceutical industry.

Conclusion

With an undeniable passion for innovation and a remarkable portfolio of patents, Iain Robert Greig continues to push the boundaries of science. His contributions to therapeutic compounds not only highlight his ingenuity as an inventor but also reflect a broader commitment to advancing medicine for the benefit of society.

This text is generated by artificial intelligence and may not be accurate.